In last trading session, CVS Health Corp (NYSE:CVS) saw 5.83 million shares changing hands with its beta currently measuring 0.60. Company’s recent per share price level of $63.8 trading at -$0.14 or -0.22% at ring of the bell on the day assigns it a market valuation of $80.71B. That closing price of CVS’s stock is at a discount of -13.65% from its 52-week high price of $72.51 and is indicating a premium of 31.72% from its 52-week low price of $43.56. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 6.36 million shares which gives us an average trading volume of 8.62 million if we extend that period to 3-months.
For CVS Health Corp (CVS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.67. Splitting up the data highlights that, out of 20 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 6 suggested the stock as a Hold whereas 14 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 1.46 in the current quarter.
CVS Health Corp (NYSE:CVS) trade information
Upright in the red during last session for losing -0.22%, in the last five days CVS remained trading in the red while hitting it’s week-highest on Thursday, 07/10/25 when the stock touched $63.8 price level, adding 4.61% to its value on the day. CVS Health Corp’s shares saw a change of 8.14% in year-to-date performance and have moved -4.29% in past 5-day. CVS Health Corp (NYSE:CVS) showed a performance of -5.43% in past 30-days. Number of shares sold short was 18.71 million shares which calculate 2.22 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 78 to the stock, which implies a rise of 18.21% to its current value. Analysts have been projecting 77 as a low price target for the stock while placing it at a high target of 79. It follows that stock’s current price would drop -20.69% in reaching the projected high whereas dropping to the targeted low would mean a loss of -20.69% for stock’s current value.
CVS Health Corp (CVS) estimates and forecasts
This year revenue growth is estimated to rise 3.84% from the last financial year’s standing.
18 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 94.75B for the same. And 18 analysts are in estimates of company making revenue of 97.73B in the next quarter. Company posted 91.23B and 95.43B of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -6.37% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 12.99% while estimates for its earnings growth in next 5 years are of 14.07%.
CVS Dividends
CVS Health Corp is more likely to be releasing its next quarterly report on 2025-May-01 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt. With an annual yield of 4.17%, the share has a forward dividend of 2.66 which implies that company’s dividend yield remained growing in trailing twelve months while having a 5 year average dividend yield of 3.13%.
CVS Health Corp (NYSE:CVS)’s Major holders
Insiders are in possession of 1.07% of company’s total shares while institution are holding 87.36 percent of that, with stock having share float percentage of 88.31%. Investors also watch the number of corporate investors in a company very closely, which is 87.36% institutions for CVS Health Corp that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at CVS for having 116.35 million shares of worth $6.87 billion. And as of 2024-06-30, it was holding 9.2635 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 100.15 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.9738 of outstanding shares, having a total worth of $5.91 billion.
On the other hand, Dodge & Cox Funds-Dodge & Cox Stock Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 48.22 shares of worth $3.08 billion or 3.81% of the total outstanding shares. The later fund manager was in possession of 39.83 shares on Mar 31, 2025 , making its stake of worth around $2.54 billion in the company or a holder of 3.15% of company’s stock.
